Literature DB >> 5982363

[Verrucae vulgaris and neurocirculatory asthenia].

H Kaffarnik, R Juchems.   

Abstract

Entities:  

Mesh:

Year:  1966        PMID: 5982363

Source DB:  PubMed          Journal:  Arch Klin Exp Dermatol        ISSN: 0300-8614


× No keyword cloud information.
  17 in total

1.  [CONTRIBUTION TO THE EPIDEMIOLOGY OF WARTS].

Authors:  K BOSSE; E CHRISTOPHERS
Journal:  Hautarzt       Date:  1964-02       Impact factor: 0.751

2.  CIRCULATION TIMES IN PATIENTS WITH NEUROCIRCULATORY ASTHENIA.

Authors:  R H JUCHEMS
Journal:  Am Heart J       Date:  1964-05       Impact factor: 4.749

3.  [STUDIES ON THE SYMPTOMATOLOGY, INCIDENCE AND LABORATORY DIAGNOSIS OF FUNCTIONAL HEART DISEASES (DA COSTA SYNDROME)].

Authors:  R JUCHEMS
Journal:  Med Welt       Date:  1963-11-23

4.  Histochemical observations of verruca vulgaris.

Authors:  M G WILLIAMS
Journal:  J Invest Dermatol       Date:  1961-10       Impact factor: 8.551

5.  [Effects of peripheral vascular diseases on the clinical picture of damage caused by cold and on skin infections].

Authors:  E KEINING
Journal:  Dermatol Wochenschr       Date:  1952

6.  [Electron microscopic study of the human warts].

Authors:  S ODA
Journal:  Hifuka Kiyo       Date:  1961-05

7.  Virus-like particles and inclusion bodies in skin papillomas.

Authors:  M J STRAUSS; H BUNTING; J L MELNICK
Journal:  J Invest Dermatol       Date:  1950-12       Impact factor: 8.551

8.  The nature of the inclusion body of verruca vulgaris; a histochemical study of nucleotids.

Authors:  H BLANK; M BUERK; F WEIDMAN
Journal:  J Invest Dermatol       Date:  1951-01       Impact factor: 8.551

9.  [Minute volume, stroke volume and peripheral resistance in neurocirculatory asthenia; examinations using the indicator dilution technic].

Authors:  R Juchems
Journal:  Cardiologia       Date:  1966

10.  A cytological and cytochemical investigation of the development of the viral papilloma of human skin.

Authors:  D P BLOCH; G C GODMAN
Journal:  J Exp Med       Date:  1957-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.